Literature DB >> 15691868

Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice.

Edward S Kimball1, Jeffrey M Palmer, Michael R D'Andrea, Pamela J Hornby, Paul R Wade.   

Abstract

Oil of mustard (OM) is a potent neuronal activator that promotes allodynia and hyperalgesia within minutes of application. In this study, OM was used to induce an acute colitis. We also investigated whether intracolonic OM-induced inflammation alters gastrointestinal (GI) function over a longer time frame as a model of postinflammatory irritable bowel syndrome (PI-IBS). Mice given a single administration of 0.5% OM developed a severe colitis that peaked at day 3, was reduced at day 7, and was absent by day 14. At the peak response, there was body weight loss, colon shrinkage, thickening and weight increases, distension of the proximal colon, and diarrhea. Macroscopic inspection of the distal colon revealed a discontinuous pattern of inflammatory damage and occasional transmural ulceration. Histological examination showed loss of epithelium, an inflammatory infiltrate, destruction of mucosal architecture, edema, and loss of circular smooth muscle architecture. OM administration increased transit of a carmine dye bolus from 58% of the total length of the upper GI tract in untreated age-matched controls to as high as 74% when tested at day 28 post-OM. Mice in the latter group demonstrated a significantly more sensitive response to inhibition of upper GI transit by the mu-opioid receptor agonist loperamide compared with normal mice. OM induces a rapid, acute, and transient colitis and, in the longer term, functional changes in motility that are observed when there is no gross inflammation and thereby is a model of functional bowel disorders that mimic aspects of PI-IBS in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691868     DOI: 10.1152/ajpgi.00444.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  25 in total

Review 1.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

2.  Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons.

Authors:  Zhishan Li; Alcmène Chalazonitis; Yung-Yu Huang; J John Mann; Kara Gross Margolis; Qi Melissa Yang; Dolly O Kim; Francine Côté; Jacques Mallet; Michael D Gershon
Journal:  J Neurosci       Date:  2011-06-15       Impact factor: 6.167

3.  Colonic elongation inhibits pellet propulsion and migrating motor complexes in the murine large bowel.

Authors:  Dante J Heredia; Eamonn J Dickson; Peter O Bayguinov; Grant W Hennig; Terence K Smith
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

4.  Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.

Authors:  Kara Gross Margolis; Korey Stevanovic; Zhishan Li; Qi Melissa Yang; Tamas Oravecz; Brian Zambrowicz; Kanchan G Jhaver; Alexander Diacou; Michael D Gershon
Journal:  Gut       Date:  2013-06-07       Impact factor: 23.059

Review 5.  Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome.

Authors:  Hong-Yan Qin; Justin C Y Wu; Xu-Dong Tong; Joseph J Y Sung; Hong-Xi Xu; Zhao-Xiang Bian
Journal:  J Gastroenterol       Date:  2010-09-17       Impact factor: 7.527

6.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

7.  Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis.

Authors:  Martin A Storr; Catherine M Keenan; Hong Zhang; Kamala D Patel; Alexandros Makriyannis; Keith A Sharkey
Journal:  Inflamm Bowel Dis       Date:  2009-11       Impact factor: 5.325

Review 8.  Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging.

Authors:  Donald D Price; Jason G Craggs; QiQi Zhou; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Neuroimage       Date:  2009-04-16       Impact factor: 6.556

9.  Visceral and somatic hypersensitivity in TNBS-induced colitis in rats.

Authors:  QiQi Zhou; Donald D Price; Robert M Caudle; G Nicholas Verne
Journal:  Dig Dis Sci       Date:  2007-08-17       Impact factor: 3.199

10.  Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.

Authors:  Kara Gross Margolis; Zhishan Li; Korey Stevanovic; Virginia Saurman; Narek Israelyan; George M Anderson; Isaac Snyder; Jeremy Veenstra-VanderWeele; Randy D Blakely; Michael D Gershon
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.